金彩汇

    long-acting interferon drug product company in Hepatitis and Cytokines
    Home / Product Category / Reagents / Interferons / Human Interferon α-2α
    Human Interferon α-2α

    loading

    Human Interferon α-2α Human Interferon α-2α

    loading

    Human Interferon α-2α

    Strength:
    Availability:
    Quantity:
     
     
    • SJC01

    • 20μg, 100μg

    Specifications and Use

    Description:

    Recombinant human IFN a-2a produced in Yeast is a single, non-glycosylated, polypeptide chain containing 165 amino acids, two pairs of disulfide bonds and having a molecular mass of approximately 19.2kD.

    Source: Yeast.

    Molecular Mass: Approximately 19.2kD.

    Purity: ≥97%.

    Endotoxin Level: <1EU/µg, determined by the LAL method.

    Biological Activity:

    Bioactivity is detected using cytopathic effect inhibition assay method, MDBK cell (Madin-Darby bovine kidney) as dependent cell strain. The specific activity shall be not less than 2.0×108 IU/mg.

    Formulation:

    Lyophilized from a 0.2μm filtered solution in 20mM Phosphate buffer.

    Reconstitution:

    It is recommended to centrifuge at 10,000rpm for 30-60 sec or 3000rpm for 5 min before opening the tube, and then reconstitute with 0.2ml sterile water.

    Storage:

    • Lyophilized samples are stable for 36 months from date of manufacture at -20℃ to -70℃.

    • Upon reconstitution, this cytokine can be stored under sterile conditions at 2- 8℃ for one month or at -20℃ to -70℃ in a manual defrost freezer for three months without detectable loss of activity.

    • Avoid repeated freeze-thaw cycles.


    For Laboratory Use Only.


    facebook sharing button
    twitter sharing button
    line sharing button
    wechat sharing button
    linkedin sharing button
    pinterest sharing button
    whatsapp sharing button
    sharethis sharing button
    Previous: 
    Next: 

    Related News

    content is empty!

    Facebook
    Twitter
    LinkedIn
    Instagram

    WELCOME

    Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
    Leave a Message
    Get In Touch